Major step towards personalised medicine against hereditary autoimmune deficiency

August 14, 2014

Researchers at Karolinska Institutet in Sweden have found a method to repair the gene mutation causing agammaglobulinemia, an autoimmune deficiency disease that almost exclusively affects boys and in which the body lacks the ability to produce immunoglobulins (gamma globulin). The disease is characterised by recurring bacterial infections, mainly in the respiratory system, and persons who suffer from the illness currently need life-long gamma globulin treatment.

"Although there is a lot of research left to be done, the findings indicate that we may be able to treat some patients in the future," says Edvard Smith, Professor at the Department of Laboratory Medicine at Karolinska Institutet and one of the researchers behind the study that is presented in the Journal of Clinical Investigation.

Agammaglobulinemia is a rare, hereditary disease that is caused by a mutation which results in a lack of the enzyme BTK. BTK plays an important role in the signalling of white blood cells and thus in developing and maintaining an effective autoimmune system. In the new study, the researchers show that it is possible to repair faulty RNA and recreate BTK in lymphocytes, . The new study emanates from the same research group at Karolinska Institutet that previously identified the predisposition for sex-linked agammaglobulinemia (XLA).

It is previously known that synthetic building blocks in our genetic make-up (known as oligonucleotides) can modify the RNA and recreate truncated forms of the protein that is missing in severe muscular dystrophy. The new study shows that it is possible to experimentally correct the defect and recreate an intact BTZ enzyme for a Swedish family with XLA. The therapy has been customised for this particular mutation and is thereby a genuine example of "personalised medicine". The researchers utilised molecular biological methods and created a mouse which carries the gene in question. The mice also lacked enzymes of their own, as their genes were inactivated.

"We have been able to show how synthetic oligonucleotides can correct RNA both in patient cells in a test tube, and in living animals," says Edvard Smith.

The number of new cases of agammaglobulinemia is estimated at 6 in one million births, which means that there is roughly one boy born with the disease in Sweden every other year. BTK has received renewed attention as it has been discovered that the protein also plays an important role in various types of blood cancer that have their origin in immune cells. A new medicine that blocks the function of the BTK enzyme was recently approved for the treatment of leukaemia and lymphoma in the USA.

The study has been financed using funds from the Swedish Cancer Society, the Swedish Research Council and Stockholm County Council (ALF), among others.

Explore further: Study identifies rational drug combinations that may overcome mantle cell lymphoma resistance to ibrutinib

More information: 'Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model' Burcu Bestas, Pedro M.D. Moreno, K. Emelie M. Blomberg, Dara K. Mohammad, Amer F. Saleh, Tolga Sutlu, Joel Z. Nordin, Peter Guterstam, Manuela O. Gustafsson, Shabnam Kharazi, Barbara Piatosa, Thomas C. Roberts, Mark A. Behlke, Matthew J.A. Wood, Michael J. Gait, Karin E. Lundin, Samir EL Andaloussi, Robert Månsson, Anna Berglöf, Jesper Wengel, och C.I. Edvard Smith, Journal of Clinical Investigation, 8 August 2014, DOI: 10.1172/JCI76175

Related Stories

Study identifies rational drug combinations that may overcome mantle cell lymphoma resistance to ibrutinib

August 8, 2014
Genomic analyses of tumor and healthy tissue from patients with mantle cell lymphomas that fail to respond to treatment with the anticancer drug ibrutinib (Imbruvica) or initially respond but then stop responding and progress, ...

A single enzyme plays a critical role in helping the body effectively fight viral infection

August 15, 2012
The body’s initial response to invading bacteria or viruses is mediated by the innate immune system, wherein cells secrete signaling factors called cytokines that promote inflammation and stimulate a generalized counterattack ...

Levels of vitamin D in newborn babies and multiple sclerosis show no connection

August 11, 2014
(Medical Xpress)—There was no association between levels of vitamin D in newborn babies and the risk of developing multiple sclerosis in adulthood. This is the observation made by researchers at Karolinska Institutet in ...

Scientists discover 'switch' to boost anti-viral response to fight infectious diseases

May 11, 2012
Singapore scientists from Bioprocessing Technology Institute (BTI) under the Agency of Science, Technology and Research (A*STAR) have for the first time, identified the molecular ‘switch’ that directly triggers ...

Study confirms target of potent chronic leukemia drug

December 19, 2013
A new study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) helps confirm that a molecule targeted ...

Recommended for you

Study suggests same gut bacteria can trigger different immune responses depending on environment

July 24, 2017
(Medical Xpress)—A group of researchers affiliated with several institutions in the U.S. has found that one type of gut bacteria triggers different kinds of immune responses depending on the state of the environment they ...

Genetic immune deficiency could hold key to severe childhood infections

July 18, 2017
A gene mutation making young children extremely vulnerable to common viruses may represent a new type of immunodeficiency, according to a University of Queensland researcher.

What are the best ways to diagnose and manage asthma?

July 18, 2017
What are the best ways to diagnose and manage asthma in adults? This can be tricky because asthma can stem from several causes and treatment often depends on what is triggering the asthma.

Large multi-ethnic study identifies many new genetic markers for lupus

July 17, 2017
Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus.

Study finds molecular explanation for struggles of obese asthmatics

July 17, 2017
A large, bouquet-shaped molecule called surfactant protein A, or SP-A, may explain why obese asthma patients have harder-to-treat symptoms than their lean and overweight counterparts, according to a new study led by scientists ...

Team identifies potential cause for lupus

July 14, 2017
Leading rheumatologist and Feinstein Institute for Medical Research Professor Betty Diamond, MD, may have identified a protein as a cause for the adverse reaction of the immune system in patients suffering from lupus. A better ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.